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The following model input parameters were identified from published primary studies: the prevalence of familial hypercholesterolaemia; the probability of a high cholesterol result; the probability of a low second cholesterol test; the probability of familial hypercholesterolaemia given a high cholesterol; and the age-specific death rates from familial hypercholesterolaemia, with and without treatment with statins.
Study designs and other criteria for inclusion in the review
Not reported.
Sources searched to identify primary studies
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
The model input parameters were established from three primary studies.
Methods of combining primary studies
Investigation of differences between primary studies
Results of the review
The following model input parameters were identified: the prevalence of familial hypercholesterolaemia was 0.002 in the universal screening population and 0.5 in the family screening population; the probability of a high cholesterol result was 0.05 in the universal screening population and 0.4991 in the family screening population; the probability of a low second cholesterol test was 0.065 in the universal screening population and 0.065 in the family screening population; and the probability of familial hypercholesterolaemia given a high cholesterol level was 0.038 in the universal screening population and 0.9517 in the family screening population.
